The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016
Open accessAbstract
Importance: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder. Previous surveys have reported a steady increase in ASD prevalence in US children over the past decades. Several behavioral therapies and medications have been developed to treat the symptoms of ASD; however, little is known about the current status of treatment usage for children diagnosed as having ASD. Objective: To estimate the prevalence and treatment patterns of ASD among US children using nationally representative data. Design, Setting, and Participants: This study used data from the 2016 National Survey of Children's Health, a nationwide, population-based, cross-sectional survey. We included 43 032 children aged 3 to 17 years. Data were collected through questionnaires completed by a parent or guardian. Data were analyzed from February 2018 to March 2018. Main Outcomes and Measures: Outcome variables included ASD diagnosed by a physician or health professional and the use of behavioral treatment or medication treatment among children with ASD. Results: Of the 43 032 included participants, 22 072 (51.3%) were male, and the mean (SD) age was 10.7 (4.4) years. The weighted prevalence of ever-diagnosed ASD and current ASD were 2.79% (95% CI, 2.46-3.12) and 2.50% (95% CI, 2.21-2.79), respectively. The state-level prevalence of ever-diagnosed ASD varied from 1.54% (95% CI, 0.60-2.48) in Texas to 4.88% (95% CI, 2.72-7.05) in Florida. Nationally, about 70% of children with current ASD (70.5%; 95% CI, 65.1-75.8) were treated; 43.3% (95% CI, 37.4-49.2) received behavioral treatment only, 6.9% (95% CI, 3.7-10.1) received medication treatment only, and 20.3% (95% CI, 16.5-24.1) received both behavioral and medication treatments. The remaining 29.5% (95% CI, 24.2-34.9) of children with current ASD did not receive either behavioral or medication treatment. Conclusions and Relevance: This study showed that the prevalence of ASD in the United States was relatively high, and it varied substantially across US states. Almost 30% of US children with ASD did not receive behavioral or medication treatment, which calls for a critical need to understand and address the barriers for those children to receive appropriate treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
RetractedThe Changing Epidemiology of Autism Spectrum Disorders
Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., Park, B. Y., Snyder, N. W., Schendel, D., Volk, H., et al. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044318 · Cited by 1,011
Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007
Kogan, M. D., Blumberg, S. J., Schieve, L. A., Boyle, C. A., Perrin, J. M., Ghandour, R. M., Singh, G. K., Strickland, B. B., Trevathan, E., & van Dyck, P. C. (2009) · Pediatrics · doi:10.1542/peds.2009-1522 · Cited by 892
Dawson, G., Jones, E. J. H., Merkle, K., Venema, K., Lowy, R., Faja, S., Kamara, D., Murias, M., Greenson, J., Winter, J., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.018 · Cited by 799
Optimal outcome in individuals with a history of autism
Fein, D., Barton, M., Eigsti, I., Kelley, E., Naigles, L., Schultz, R. T., Stevens, M., Helt, M., Orinstein, A., Rosenthal, M., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12037 · Cited by 584
Pickles, A., Le Couteur, A., Leadbitter, K., Salomone, E., Cole-Fletcher, R., Tobin, H., Gammer, I., Lowry, J., Vamvakas, G., Byford, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31229-6 · Cited by 519
Six Developmental Trajectories Characterize Children With Autism
Fountain, C., Winter, A. S., & Bearman, P. S. (2012) · Pediatrics · doi:10.1542/peds.2011-1601 · Cited by 372
Ospina, M. B., Krebs Seida, J., Clark, B., Karkhaneh, M., Hartling, L., Tjosvold, L., Vandermeer, B., & Smith, V. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003755 · Cited by 366
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Complementary and alternative medicine use in a large pediatric autism sample
Perrin, J. M., Coury, D. L., Hyman, S. L., Cole, L., Reynolds, A. M., & Clemons, T. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900e · Cited by 135
Research works printed but not linked: 19
- Lai, 2014, Autism., Lancet, 383, 896, 10.1016/S0140-6736(13)61539-1 · DOI · Paper page
- Modabbernia, Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses, Mol Autism
- Geschwind, 2015, Gene hunting in autism spectrum disorder: on the path to precision medicine., Lancet Neurol, 14, 1109, 10.1016/S1474-4422(15)00044-7 · DOI · Paper page
- Buescher, 2014, Costs of autism spectrum disorders in the United Kingdom and the United States., JAMA Pediatr, 168, 721, 10.1001/jamapediatrics.2014.210 · DOI · Paper page
- Zablotsky, 2015, Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey., Natl Health Stat Report, 1
- Blumberg, 2013, Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012., Natl Health Stat Report, 1
- Xu, 2018, Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016., JAMA, 319, 81, 10.1001/jama.2017.17812 · DOI · Paper page
- Maglione, 2012, Nonmedical interventions for children with ASD: recommended guidelines and further research needs., Pediatrics, 130, S169, 10.1542/peds.2012-0900O · DOI · Paper page
- Reichow, 2012, Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)., Cochrane Database Syst Rev, 10, CD009260
- Witwer, 2005, Treatment incidence and patterns in children and adolescents with autism spectrum disorders., J Child Adolesc Psychopharmacol, 15, 671, 10.1089/cap.2005.15.671 · DOI
- Aman, 2003, Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio., J Autism Dev Disord, 33, 527, 10.1023/A:1025883612879 · DOI · Paper page
- Zablotsky, 2017, Estimated prevalence of children with diagnosed developmental disabilities in the United States, 2014-2016., NCHS Data Brief, 1
- Ali, 2018, Utilization of mental health services by preschool-aged children with private insurance coverage., Adm Policy Ment Health, 45, 731, 10.1007/s10488-018-0858-x · DOI
- Myers, 2007, Management of children with autism spectrum disorders., Pediatrics, 120, 1162, 10.1542/peds.2007-2362 · DOI · Paper page
- Orinstein, 2014, Intervention for optimal outcome in children and adolescents with a history of autism., J Dev Behav Pediatr, 35, 247, 10.1097/DBP.0000000000000037 · DOI · Paper page
- Levy, 2015, Complementary and alternative medicine treatments for children with autism spectrum disorders., Child Adolesc Psychiatr Clin N Am, 24, 117, 10.1016/j.chc.2014.09.004 · DOI
- Salomone, 2015, Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe., Eur J Pediatr, 174, 1277, 10.1007/s00431-015-2531-7 · DOI
- Höfer, 2017, Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review., Autism, 21, 387, 10.1177/1362361316646559 · DOI
- Weitlauf, 2014, Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update
Cited by
Global prevalence of autism: A systematic review update
Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxena, S., Yusuf, A., Shih, A., & Elsabbagh, M. (2022) · Autism Research · doi:10.1002/aur.2696 · Cited by 3,117
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets
Postema, M. C., van Rooij, D., Anagnostou, E., Arango, C., Auzias, G., Behrmann, M., Filho, G. B., Calderoni, S., Calvo, R., Daly, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13005-8 · Cited by 267
Schuck, R. K., Tagavi, D. M., Baiden, K. M. P., Dwyer, P., Williams, Z. J., Osuna, A., Ferguson, E. F., Jimenez Muñoz, M., Poyser, S. K., Johnson, J. F., et al. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05316-x · Cited by 208
Delobel-Ayoub, M., Saemundsen, E., Gissler, M., Ego, A., Moilanen, I., Ebeling, H., Rafnsson, V., Klapouszczak, D., Thorsteinsson, E., Arnaldsdóttir, K. M., et al. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04328-y · Cited by 128
Pantazakos, T., & Vanaken, G.-J. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1225152 · Cited by 59
“study of over 43,000 children diagnosed with autism found that about 63% were receiving ABA (Xu et al., 2016).”
BackgroundLiu, X., Zou, M., Sun, C., Wu, L., & Chen, W.-X. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-04951-8 · Cited by 58
Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates
DiCarlo, G. E., & Wallace, M. T. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.017 · Cited by 39
Yan, X., Li, Y., Li, Q., Li, Q., Xu, G., Lu, J., & Yang, W. (2026) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06390-7 · Cited by 11
“In addition, the National Institutes of Health in the United States have been paying strong attention to the development and evaluation of treatments for ASD in the past decade (Cervantes et al., 2021), and with the implementation of mandatory health insurance laws for ASD (Barry et al., 2017; Chatterji et al., Table…”
InfluentialSelf-citation
Metadata
- Authors
- Xu, G., Strathearn, L., Liu, B., O’Brien, M., Kopelman, T. G., Zhu, J., Snetselaar, L. G., & Bao, W.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2019-02-01
- Volume
- 173
- Issue
- 2
- Pages
- 153
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2903391888
- Cited by
- 212
- References
- 11
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.